Coherus BioSciences Inc CHRS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
17.70quote price arrow up+0.14 (+0.80%)
Volume
309,422
Close
17.56quote price arrow up+1.53 (+9.54%)
Volume
3,295,509
52 week range
12.21 - 22.22
Loading...
  • Open16.25
  • Day High17.78
  • Day Low16.16
  • Prev Close16.03
  • 52 Week High22.22
  • 52 Week High Date01/27/21
  • 52 Week Low12.21
  • 52 Week Low Date08/06/21

Key Stats

  • Market Cap1.343B
  • Shares Out76.48M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change1.04

KEY STATS

  • Open16.25
  • Day High17.78
  • Day Low16.16
  • Prev Close16.03
  • 52 Week High22.22
  • 52 Week High Date01/27/21
  • 52 Week Low12.21
  • 52 Week Low Date08/06/21
  • Market Cap1.343B
  • Shares Out76.48M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change1.04

RATIOS/PROFITABILITY

  • EPS (TTM)-2.31
  • P/E (TTM)-7.59
  • Fwd P/E (NTM)-201.84
  • EBITDA (MRQ)-138.057M
  • ROE (MRQ)-89.40%
  • Revenue (MRQ)394.65M
  • Gross Margin (MRQ)88.63%
  • Net Margin (MRQ)-41.86%
  • Debt To Equity (MRQ)259.94%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Coherus BioSciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab (Avastin); Immunology (Anti-TNF) biosimilar candidates etanercept (Enbrel) and adalimumab (Humira); Ophthalmology biosimilar candidate ranibizumab (Lucentis)...
Dennis Lanfear
Chairman
Vincent Anicetti
Chief Operating Officer
McDavid Stilwell
Chief Financial Officer
Address
333 Twin Dolphin Dr Ste 600
Redwood City, CA
94065-1442
United States

Top Peers

SYMBOLLASTCHG%CHG
MOR
MorphoSys AG
12.00+0.02+0.17%
ICPT
Intercept Pharmaceuticals Inc
15.93+0.52+3.37%
MDXG
MiMedx Group Inc
6.15+0.63+11.41%
ACAD
ACADIA Pharmaceuticals Inc
16.70+0.58+3.60%
PBYI
Puma Biotechnology Inc
6.90-0.05-0.72%